antibiot
broadspectrum
agent
rapidli
chang
normal
flora
mouth
gastrointestin
gi
tract
surgeri
especi
thorac
abdomin
neurosurgeri
increas
risk
aspir
chronic
lung
diseas
advanc
age
immunosuppress
c
etiolog
agent
common
gramneg
bacteria
klebsiella
sp
escherichia
coli
pseudomona
aeruginosa
enterobact
sp
acinetobact
sp
anoth
help
approach
consid
like
pathogen
accord
time
hospit
pneumonia
develop
lateonset
pneumonia
day
hospit
usual
character
resist
organ
clinic
manifest
patient
icu
especi
intub
sedat
manifest
usual
symptom
pneumonia
cough
chest
pain
dyspnea
patient
neutropen
mount
inflammatori
respons
therefor
sputum
show
purul
materi
subtl
chang
oxygen
fever
clinic
deterior
clue
diagnosi
pneumonia
intub
patient
leukocytosi
leukopenia
first
manifest
occult
pneumonia
instanc
ie
pneumocysti
pneumonia
presenc
spontan
pneumothorax
first
indic
pulmonari
involv
thick
foulsmel
sputum
characterist
anaerob
aspir
pneumonia
durat
therapi
well
defin
author
agre
treat
gramneg
anaerob
pneumonia
day
gramposit
process
usual
treat
day
atyp
pneumonia
receiv
week
antimicrobi
therapi
candida
pneumonia
requir
prolong
treatment
g
amphotericin
b
total
dose
term
given
world
health
organ
describ
rapidli
progress
respiratori
ill
document
outbreak
china
hong
kong
vietnam
singapor
canada
presum
pathogen
coronaviru
spread
person
person
via
droplet
sewag
water
potenti
human
fece
hypothes
bat
primari
reservoir
diseas
mortal
rate
sar
high
sever
case
respiratori
function
may
worsen
second
week
ill
progress
ard
twostag
ill
prodrom
day
includ
fever
malais
headach
myalgia
diarrhea
may
occur
respiratori
phase
day
nonproduct
cough
dyspnea
rapidli
progress
respiratori
failur
rapid
diagnosi
sar
made
revers
transcriptas
pcr
respiratori
tract
sampl
plasma
earli
ill
current
treatment
avail
ill
except
support
care
intens
care
unit
prevent
measur
sar
mainli
focus
travel
advisori
countri
citi
activ
outbreak
effort
underway
prepar
vaccin
prevent
sar
case
sepsi
associ
mortal
estim
occur
annual
despit
improv
antimicrobi
therapi
support
care
incid
mortal
associ
sepsi
declin
part
consequ
array
medic
advanc
place
patient
increas
risk
develop
infect
potenti
sepsi
e
prognosi
mortal
sepsi
function
sever
physiolog
derang
durat
ill
number
organ
system
failur
organ
system
includ
limit
lung
kidney
liver
pulmonari
system
becom
dysfunct
result
clinic
entiti
known
adult
respiratori
distress
syndrom
ard
sequenc
term
multipl
organ
dysfunct
syndrom
mod
mod
common
caus
demis
patient
experi
uncontrol
inflamm
infect
clinic
case
definit
see
tabl
sever
febril
ill
rash
erythroderma
follow
desquam
hypotens
syncop
multipl
organ
system
involv
least
four
follow
mucou
membran
gi
muscular
acut
mening
medic
emerg
requir
earli
recognit
rapid
diagnosi
precis
antimicrobi
therapi
aggress
icu
support
acut
ill
patient
goal
therapi
institut
treatment
patholog
process
inflamm
produc
irrevers
progress
death
time
essenti
situat
empir
therapi
institut
immedi
diagnosi
made
base
recognit
commun
versu
hospit
andor
postop
process
communityacquir
mening
usual
treatment
includ
thirdgener
cephalosporin
ie
cefotaxim
g
iv
h
ceftriaxon
g
h
vancomycin
ad
regimen
cultur
suscept
result
avail
number
critic
ill
patient
impair
host
defens
mechan
admit
icu
dramat
increas
recent
year
knowledg
recognit
basic
defici
enabl
physician
predict
type
site
infect
allow
institut
earli
empir
therapi
see
tabl
b
immunocompromis
patient
admit
icu
categor
accord
time
acquisit
infect
hospitalacquir
infect
differ
etiolog
agent
compar
commun
despit
basic
immunolog
defect
prolong
icu
stay
expect
earli
placement
subcutan
cathet
recommend
j
patient
high
fever
requir
special
attent
fluid
manag
k
antibiot
interact
mani
drug
see
previou
tabl
l
druginduc
fever
uncommon
common
agent
antibiot
h
phenytoin
fever
may
last
sever
day
even
appropri
antimicrobi
therapi
institut
n
close
follow
clinic
situat
import
laboratori
result
antibiot
kinet
pharmacokinet
antibiot
depend
sever
factor
volum
distribut
v
antimicrobi
calcul
b
antibiot
adjust
renal
dysfunct
critic
ill
patient
common
patient
receiv
aminoglycosid
dosag
modif
requir
accord
aminoglycosid
clearanc
aminoglycosid
clearanc
cr
c
c
cr
creatinin
clearanc
mlmin
tabl
fact
atyp
mycobacteria
commonli
encount
critic
care
set
depict
tabl
